Citation Impact
Citing Papers
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Multiplex single-cell visualization of nucleic acids and protein during HIV infection
2017
HIV evolution and diversity in ART-treated patients
2018
Nuclear landscape of HIV-1 infection and integration
2016
Filgotinib suppresses HIV-1–driven gene transcription by inhibiting HIV-1 splicing and T cell activation
2020
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
2020
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Oncogenes and signal transduction
1991 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Why and where an HIV cure is needed and how it might be achieved
2019 Nature
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen.
1985
The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor.
1985 StandoutNobel
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
1983 StandoutNature
Production of large amounts of hydrogen peroxide by human tumor cells.
1991 Standout
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
1995 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
HIV-1 Vpr Reprograms CLR4 DCAF1 E3 Ubiquitin Ligase to Antagonize Exonuclease 1-Mediated Restriction of HIV-1 Infection
2018
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus
2019 StandoutNobel
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein
1981 Nature
A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity
1990
Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
1993 StandoutNobel
14-3-3 Proteins: Structure, Function, and Regulation
2000 Standout
A catalogue of splice junction sequences
1982 Standout
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
1988 Standout
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
1992 Standout
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
1991 Standout
Matrix Metalloproteinases: A Review
1993 Standout
Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector
1983 StandoutNobel
The p110α Isoform of Phosphatidylinositol 3-Kinase Is Essential for Polyomavirus Middle T Antigen-Mediated Transformation
2007
Tumors: Wounds That Do Not Heal
1986 Standout
Multimerization of polyomavirus middle-T antigen
1997
Works of Ross A. Pollack being referenced
Defective proviruses rapidly accumulate during acute HIV-1 infection
2016
Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape
2017
Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells
2016
Early Mutants of Polyoma Virus (dl8 and dl23) with Altered Transformation Properties: Is Polyoma Virus Middle T Antigen a Transforming Gene Product?
1980
Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity
2017